Cannabis use is associated with an increased risk for adverse cardiovascular events, including myocardial infarction ...

Type 1 diabetes was associated with less myocardial infarction, percutaneous coronary intervention, stroke, and limb ischemia than type 2.

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

A new study of 4.6 million people found that cannabis users were more likely to experience heart failure, strokes and cardiac ...

Products must note that they can increase blood pressure, but boxed warnings about adverse cardiovascular events can be removed, the FDA announced.

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

A new article proposes offering citizens over 50 a combined medication that includes a cocktail of blood pressure-lowering ...

Marijuana is now legal in many places, but is it safe? Two new studies add to mounting evidence that people who use cannabis ...

Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.

Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to ...